01-Sep-2022 | Facts and Factors
According to Facts and Factors, the global cell-based assays market size was worth USD 14,829.50 million in 2021 and is estimated to grow to USD 23,143.57 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.70% over the forecast period. The report analyzes the cell-based assay market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the cell-based assay market.
A cell's viability, proliferation, cytotoxicity, senescence, and death rate are all displayed using cell-based tests. These tests rely on reporter gene assays, which are well suited for cell-signaling cascade investigation because they have a high sensitivity to signal amplification from cell-signaling cascades. Frequently, high-throughput screening (HTS) formats utilize cell-based assays. Many governmental and private organizations have upped their R&D spending to find better and safer medicines. Additionally, improvements in cell-based test technology have made it possible for researchers to apply this approach for toxicity research and medication development.
Browse the full “Cell-based Assays Market Size, Share, Growth Analysis Report By Product And Services (Consumables, Cell Lines, Microplates, Probes & Labels, Other Consumables, Instruments & Software, Services), By Application (Drug Discovery, Basic Research, Other Applications), By End User (Pharmaceutical & Biopharmaceutical Companies, CROs, Academic & Research Institutes), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/cell-based-assays-market
Increased demand for cell-based assays in drug development, increased funding for cell-based research, and an increase in the number of drug discovery businesses are some of the reasons fueling the expansion of the cell-based assay market. The demand for cell-based assays has grown significantly in recent years due to the development of cell-based applications in drug discovery and technical improvements in cell-based assay methodologies. The rising incidence of lifestyle illnesses such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, and others, which still have many unmet requirements, has led to continuous R&D expenditures and is a key driver driving market expansion. Growth in cell-based assay techniques for high throughput screening procedures, such as toxicity research, drug screening, in-vitro testing, and others, is another factor driving this market. The market is also being stimulated by high-throughput screening techniques and a rise in R&D expenditures. These tests' growth is being hampered by their high costs and a lack of qualified practitioners. Furthermore, the market's participants have a lot of opportunities thanks to the rising use of label-free cell-based assays and untapped potential in developing countries.
The global cell-based assay market is segregated based on Product And Service, application, end-user, and region. Based on product and service, the market is classified into consumables, cell lines, microplates, probes & labels, other consumables, instruments & software, and services. The consumables segment dominated the market in 2021. Based on type, the market is classified into drug discovery, basic research, and other applications. Among these, drug discovery dominated the market in 2021. Based on end-user, the market is segmented into pharmaceutical & biopharmaceutical companies, CROs, and academic & research institutes. Pharmaceutical & Biopharmaceutical companies dominated the market in 2021.
The global cell-based assay market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The market for cell-based assays was dominated by North America in 2021 by region type, followed by Europe. The significant market share of the North American area may be ascribed to the region's quick uptake of cutting-edge technology, extensive drug development laws, and the availability of public and private financing for life science research. Because of the region's rapid rise in the creation and usage of cell-based assays and increased awareness of these assays for drug discovery, North America now holds a monopoly on the global market for these assays.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 14,829.50 Million |
Projected Market Size in 2028 |
USD 23,143.57 Million |
CAGR Growth Rate |
7.70% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Thermo Fisher Scientific, Promega Corporation, Enzo Biochem, Ca3 Biosciences Inc. (Neuromics), Danaher Corporation, Merck Kgaa, Becton, Dickinson And Company, Lonza Group, Perkinelmer, Charles River Laboratories, Reaction Biology Corporation, Eurofins Scientific Se, Carna Biosciences Inc, Cell Biolabs, Cell Signaling Technology, Bioagilytix Labs Inc., Aat Bioquest Inc., Pbl Assay Science, Invivogen, Bps Bioscience, and Others |
Key Segment |
By Product and Services, Application, End-user, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key players in the global cell-based assays market include Thermo Fisher Scientific, Promega Corporation, Enzo Biochem, Ca3 Biosciences Inc. (Neuromics), Danaher Corporation, Merck Kgaa, Becton, Dickinson And Company, Lonza Group, Perkinelmer, Charles River Laboratories, Reaction Biology Corporation, Eurofins Scientific Se, Carna Biosciences, Inc, Cell Biolabs, Cell Signaling Technology, Bioagilytix Labs Inc., Aat Bioquest, Inc., Pbl Assay Science, Invivogen, Bps Bioscience.
Recent Development:
- In 2020: The ImageXpress Micro-confocal High-content Imaging System was introduced by Danaher Corporation (US).
Global Cell-based Assays Market is segmented as follows:
By Product and Services
- Consumables
- Cell Lines
- Microplates
- Probes & Labels
- Other Consumables
- Instruments & Software
- Services
By Application
- Drug Discovery
- Basic Research
- Other Applications
By End-user
- Pharmaceutical & Biopharmaceutical Companies
- CROs
- Academic & Research Institutes
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
